Purchase of PAML by LabCorp

  Friday, February 24th, 2017

Letter to PAML clients from President and CEO
Francisco R. Velazquez, M.D., S.M.

Dear Valued Client:

I am writing to inform you of an important announcement.

Laboratory Corporation of America (LabCorp) is purchasing Pathology Associates Medical Laboratories (PAML) and PAML's interest in several joint ventures. LabCorp will assume sole ownership once the transaction is complete.

Read More

PAML President and CEO asked to sit on Life Science Washington Executive Committee

  Wednesday, February 8th, 2017

SPOKANE, Washington (December 28, 2016) Dr. Francisco Velázquez, President and CEO of Pathology Associates Medical Laboratories, LLC (PAML), was asked to sit on the Executive Committee for Life Science Washington.

Read More

PAML President and CEO to serve on University of Washinton School of Medicine-Gonzaga Regional Health Partnership Advisory Board

  Wednesday, February 8th, 2017

SPOKANE, Washington (December 28, 2016) —Pathology Associates Medical Laboratories, LLC (PAML) President and CEO, Dr. Francisco Velázquez, has been appointed to the University of Washington School
of Medicine – Gonzaga Regional Health Partnership’s Spokane Advisory Board.

“It’s an honor to have been selected to serve on this board. Medical education, research, and progression have been a driving force in my career and I am looking forward to continuing to open dialogue and expand the industry,” said Dr. Velázquez of his newly appointed position.

Read More

Fathers of Invention

  Thursday, January 5th, 2017

PAML is featured in the January issue of Business Review USA & Canada! In an engaging company report, CEO Dr. Francisco Velázquez discusses PAML’s role in the economic development of life sciences.

Read Article

Read More

Francisco R. Velázquez, M.D., S.M. to speak on panel at WSU Health Policy and Administration Program

  Friday, November 4th, 2016

SPOKANE, Washington (November 2, 2016) —Pathology Associates Medical Laboratories, LLC (PAML) President and Chief Executive Officer, Dr. Francisco R. Velázquez, was invited to participate in a panel discussing healthcare reform and population health at Washington State University’s (WSU) Riverpoint campus in Spokane, Washington on November 7, 2016.

Read More

PAML President and CEO, Keynote Speaker at Upcoming Technology Conference

  Wednesday, October 19th, 2016

SPOKANE, Washington (October 18, 2016) — Dr. Francisco R. Velázquez, President and CEO of Pathology Associates Medical Laboratories, LLC (PAML) and PAML Ventures, is set to be a Keynote Speaker at the NW Technology Conference in Bellevue, WA on October 24, 2016.

Read More

PAML President and CEO to be Awarded Business Leader of the Year

  Wednesday, October 12th, 2016

SPOKANE, Washington (September 26, 2016) —Pathology Associates Medical Laboratories, LLC (PAML) President and CEO, Dr. Francisco R. Velázquez, has been selected as the 2016 Business Leader of the Year by the Latino Hope Foundation.

Read More

PAML Sponsors Night in the Warehouse, to Benefit Second Harvest

  Wednesday, October 12th, 2016

SPOKANE, Washington (September 26, 2016) —Pathology Associates Medical Laboratories, LLC (PAML) will be sponsoring “Night at the Warehouse”, benefiting Second Harvest in Spokane, WA. The event will be held Friday, September 30th at Second Harvest.

Read More

PAML President & CEO Discusses Health Model of the Future

  Thursday, October 6th, 2016

SPOKANE, Washington (October 7, 2016) —Pathology Associates Medical Laboratories, LLC (PAML) President and CEO, Dr. Francisco Velázquez, spoke Thursday at Roche Diagnostic’s SmartLab forum in San Antonio, TX. With guests from the Mayo Clinic, the University of Texas Medical Branch, and others, Dr. Velázquez led a workshop session titled “Concierge Care: The Health Model of the Future.” In his session, Dr. Velázquez reviewed healthcare trends seen in recent years and presented on the concept of Concierge Medicine.

Read More

EarlyCDT®-Lung Webinar to be Hosted by PAML

  Friday, September 23rd, 2016

SPOKANE, Washington (September 26, 2017) —Pathology Associates Medical Laboratories, LLC (PAML) will host a webinar featuring Oncimmune USA’s Dr. James Jett, Chief Medical Officer and Dr. Laura Peek, Principal Scientist. They will be exploring “Advancements in the Early Detection of Lung Cancer” on October 12, 2016.

Read More

Pages